(Reuters) -Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug, Mounjaro, in countries like China, India, ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...

A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture ...

I had no idea this could happen. I wouldn’t have done it,” New Jersey-based former Mounjaro user James Norris, who is now visually impaired, told The Post ...

Kourtney Kardashian's ex, Scott Disick, admitted to using Mounjaro on a recent episode of The Kardashians which hit our ...

Eli Lilly plans to globally launch its diabetes and weight-loss drug, Mounjaro, in countries including China, India, Brazil, ...

Mounjaro (tirzepatide) is a brand-name injection prescribed for type 2 diabetes in adults. As with other drugs, Mounjaro can cause side effects, such as nausea, diarrhea, and appetite loss.

Weight loss drugs like Ozempic, while transformative in combating obesity, have been linked to irreversible vision impairment ...

A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...

Wegovy (semaglutide) and Mounjaro (tirzepatide) are brand-name injections. Wegovy is prescribed for weight loss and to lower cardiovascular risks. Mounjaro is approved for type 2 diabetes ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and ...